Treatment of congenital toxoplasmosis during pregnancy.
Wilson
C B
CB
D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011739:Pyrimethamine / Q000627:therapeutic use; D015572:Spiramycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy*; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*
D013449:Sulfonamides; D015572:Spiramycin; D011739:Pyrimethamine